×
Home Current Archive Editorial board
News Contact

Archive

More Filters

Contents

03.05.2018. Commentary Biochemistry
“Repeal and Replace”: What’s Next

No abstract available. Editor’s note: Changes (some predict repeal) in the Affordable Care Act is an immanent prospect that will affect all stakeholders in healthcare, including patients, providers, and innovators in telemedicine. In this article and three others included in this issue of Telehealth and Medicine Today, David Gruber and Peter ...

By David Gruber, Peter Urbanowicz

03.05.2018. Commentary Biochemistry
Obamacare: Coverage without Cost Containment

No abstract available. Editor’s note: Changes (some predict repeal) in the Affordable Care Act is an immanent prospect that will affect all stakeholders in healthcare, including patients, providers, and innovators in telemedicine. In this article and three others included in this issue of Telehealth and Medicine Today, David Gruber and Peter ...

By David Gruber, Peter Urbanowicz

No abstract available. Editor’s note: Changes (some predict repeal) in the Affordable Care Act is an immanent prospect that will affect all stakeholders in healthcare, including patients, providers, and innovators in telemedicine. In this article and three others included in this issue of Telehealth and Medicine Today, David Gruber and Peter ...

By David Gruber, Peter Urbanowicz

03.05.2018. Opinion/Perspectives/Commentary Biochemistry
Grading Obamacare, While Speculating About Trump: Separating Fact from Fiction

No abstract available. Editor’s note: Changes (some predict repeal) in the Affordable Care Act is an immanent prospect that will affect all stakeholders in healthcare, including patients, providers, and innovators in telemedicine. In this article, David Gruber and Peter Urbanowicz inform our readers and, hopefully, help prepare them for chang...

By David Gruber, Peter Urbanowicz